Evidence map›Paper›PMID 39956956›Full record

ArticleMycoses2025

Investigating Asthma After Coccidioidomycosis Among Patients With Commercial Health Insurance, United States, 2017-2022.

Kaitlin Benedict, Dallas J Smith, Angela Haczku, Amir A Zeki, Joy Hsu, Mitsuru Toda, Nicholas J Kenyon, George R Thompson

Abstract read
In one paragraph

Article in Mycoses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kaitlin BenedictMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-0458-2493
Dallas J SmithMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-5707-528X
Angela HaczkuDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
Amir A ZekiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
Joy HsuAsthma and Air Quality Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mitsuru TodaMycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nicholas J KenyonDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
George R ThompsonDepartment of Medicine, Division of Infectious Diseases, and the Department of Medical Microbiology and Immunology, University of California, Davis, Sacramento, California, USA.ORCID https://orcid.org/0000-0001-8518-5750

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Reducing Airway Smooth Muscle Tone Using Inhaled StatinsR01HL148715 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZEKI, AMIR A. · 2020 to 2024
$2.3M
Intramural CDC HHS CC999999NHLBI NIH HHS R01 HL148715NIH HHS P51 OD011107
6 · The paper itself

Abstract

backgroundThe relationship between asthma and coccidioidomycosis has not been fully described. We have hypothesised that Coccidioides could trigger inflammatory airway responses, similar to other fungi.

objectivesTo estimate the frequency of new-onset asthma-related symptoms after coccidioidomycosis and identify potentially associated factors. PATIENTS/

methodsWe used a large health insurance claims database to identify patients with coccidiomycosis with and without an asthma diagnosis code or a short-acting β

resultsThirteen per cent of 1657 patients with an asthma diagnosis code or a short-acting β

conclusionsIncreased healthcare provider awareness of asthma as a potential coccidioidomycosis complication could benefit patients, especially female patients and patients with severe pulmonary infection.

Indexed as

AsthmaCoccidioidomycosisInsurance, HealthAdolescentAdultAgedDatabases, FactualFemaleHumansMaleMiddle AgedUnited StatesYoung Adultasthmacoccidioidomycosishealth insuranceUnited States

Identifiers

PMID39956956
PMCPMC12182640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.